Double maintains 2 strategies that include VKTX - Viking Therapeutics, Inc.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| LDUR | -0.01% | $929.65M | 0.5% |
| UDN | -0.02% | $148.33M | 0.78% |
| CORN | -0.14% | $44.67M | 0.2% |
| FXE | -0.18% | $568.94M | 0.4% |
| TPMN | -0.19% | $30.70M | 0.65% |
| UNG | -0.25% | $360.54M | 1.06% |
| STXT | -0.28% | $129.40M | 0.49% |
| SCHR | 0.30% | $10.92B | 0.03% |
| UUP | 0.40% | $201.63M | 0.77% |
| TBLL | -0.42% | $2.13B | 0.08% |
| XBIL | 0.46% | $783.90M | 0.15% |
| IBTK | -0.48% | $448.89M | 0.07% |
| IBMN | -0.51% | $447.08M | 0.18% |
| VGIT | 0.54% | $31.89B | 0.04% |
| IBTL | 0.57% | $381.01M | 0.07% |
| BSMW | -0.60% | $107.45M | 0.18% |
| BSMR | 0.67% | $255.87M | 0.18% |
| IEI | -0.73% | $15.48B | 0.15% |
| SHY | 0.81% | $23.83B | 0.15% |
| BILS | -0.87% | $3.81B | 0.1356% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 60.64% | $4.82B | 0.35% |
| IBB | 51.97% | $5.26B | 0.45% |
| PBE | 50.81% | $223.19M | 0.58% |
| FBT | 47.91% | $1.01B | 0.54% |
| GNOM | 47.91% | $44.57M | 0.5% |
| PINK | 47.32% | $130.57M | 0.5% |
| QDVO | 46.04% | $83.43M | 0.55% |
| BBH | 45.48% | $330.62M | 0.35% |
| IWC | 43.30% | $818.14M | 0.6% |
| SECT | 43.27% | $2.10B | 0.78% |
| ARKG | 43.08% | $1.02B | 0.75% |
| IWO | 42.89% | $11.60B | 0.24% |
| ROBT | 42.29% | $498.76M | 0.65% |
| PTH | 42.21% | $100.85M | 0.6% |
| VBK | 42.11% | $19.01B | 0.07% |
| ONEQ | 42.09% | $8.07B | 0.21% |
| TECB | 41.91% | $438.63M | 0.3% |
| QQQJ | 41.78% | $621.52M | 0.15% |
| FXL | 41.64% | $1.37B | 0.62% |
| IWY | 41.45% | $13.97B | 0.2% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HAIN | 0.02% | $149.82M | -76.22% | 0.00% |
| HMY | 0.09% | $8.87B | +52.35% | 1.21% |
| CL | -0.32% | $74.88B | -3.64% | 2.19% |
| VZ | 0.32% | $183.79B | +6.01% | 6.18% |
| VSTA | 0.32% | $344.07M | +39.29% | 0.00% |
| MSIF | -0.39% | $769.47M | +36.17% | 7.61% |
| MKTX | 0.44% | $8.22B | +9.03% | 1.38% |
| COR | -0.47% | $56.44B | +30.86% | 0.74% |
| UUU | 0.50% | $7.17M | +101.30% | 0.00% |
| NFG | 0.56% | $7.58B | +52.77% | 2.46% |
| LMT | 0.59% | $108.37B | -0.75% | 2.81% |
| INVH | -0.64% | $19.93B | -9.72% | 3.54% |
| PPL | 0.70% | $24.79B | +21.83% | 3.15% |
| AIFU | -0.74% | $6.79B | +102.19% | 0.00% |
| LNT | 0.80% | $15.61B | +19.58% | 3.22% |
| K | -0.85% | $27.76B | +41.17% | 2.85% |
| QXO | -0.92% | $14.47B | -66.08% | 0.00% |
| HTO | 0.93% | $1.82B | -0.39% | 3.10% |
| AMT | -1.06% | $104.32B | +14.40% | 3.00% |
| FE | 1.09% | $22.95B | +3.43% | 4.32% |
Finnhub
Corporate Presentation July 2025 ...
Yahoo
Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.
Finnhub
Viking Therapeutics, Inc. added to Russell Midcap Value Index...
Finnhub
Viking Therapeutics, Inc. added to Russell 3000 Value Index...
Finnhub
Viking Therapeutics, Inc. added to Russell 2500 Value Index...
Finnhub
Viking Therapeutics, Inc. added to Russell 1000 Value Index...
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EW | -15.22% | $45.18B | -15.44% | 0.00% |
| ROL | -15.18% | $26.97B | +10.64% | 1.16% |
| PM | -9.58% | $273.81B | +73.45% | 3.06% |
| EXC | -9.04% | $43.33B | +23.58% | 3.62% |
| CBOE | -8.92% | $24.23B | +35.36% | 1.09% |
| WM | -8.89% | $89.89B | +6.28% | 1.41% |
| PULM | -8.62% | $25.57M | +219.63% | 0.00% |
| HIHO | -7.44% | $7.22M | -20.82% | 4.49% |
| WTRG | -7.20% | $10.40B | +1.01% | 3.50% |
| AWK | -6.97% | $27.36B | +9.65% | 2.21% |
| CME | -6.75% | $99.39B | +40.68% | 3.86% |
| MO | -6.74% | $99.67B | +28.77% | 6.90% |
| STG | -6.42% | $30.78M | -22.51% | 0.00% |
| YORW | -6.40% | $462.54M | -11.81% | 2.70% |
| ED | -5.98% | $36.00B | +12.64% | 3.34% |
| SCKT | -5.95% | $8.95M | +2.73% | 0.00% |
| LKQ | -5.89% | $9.96B | -7.17% | 3.10% |
| HUSA | -5.85% | $19.66M | -19.53% | 0.00% |
| PRA | -5.72% | $1.17B | +89.68% | 0.00% |
| MSEX | -5.50% | $1.00B | +5.97% | 2.41% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| GPCR | 48.68% | $1.18B | -45.42% | 0.00% |
| KRYS | 48.01% | $4.08B | -20.39% | 0.00% |
| CRNX | 46.64% | $2.76B | -33.39% | 0.00% |
| DNLI | 45.20% | $2.16B | -30.05% | 0.00% |
| ROIV | 44.70% | $7.46B | +4.68% | 0.00% |
| CIGI | 44.61% | $6.61B | +15.65% | 0.23% |
| OCUL | 43.99% | $1.51B | +41.41% | 0.00% |
| WH | 43.95% | $6.47B | +15.48% | 1.88% |
| PLXS | 43.81% | $3.77B | +33.48% | 0.00% |
| CLDX | 41.55% | $1.47B | -38.43% | 0.00% |
| CBRE | 41.53% | $42.48B | +63.07% | 0.00% |
| NOW | 41.43% | $209.17B | +28.48% | 0.00% |
| TYL | 41.05% | $25.14B | +14.65% | 0.00% |
| SYRE | 40.66% | $935.48M | -39.83% | 0.00% |
| LGND | 40.56% | $2.19B | +37.44% | 0.00% |
| IMVT | 40.52% | $2.87B | -35.84% | 0.00% |
| APGE | 40.00% | $2.64B | +18.19% | 0.00% |
| NDAQ | 39.86% | $51.40B | +48.85% | 1.10% |
| XENE | 39.74% | $2.56B | -7.61% | 0.00% |
| ARCT | 39.26% | $369.38M | -37.89% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -32.75% | $99.63M | 0.59% |
| VIXY | -32.66% | $164.54M | 0.85% |
| BTAL | -32.11% | $296.22M | 1.43% |
| IVOL | -15.46% | $347.03M | 1.02% |
| FTSD | -13.62% | $231.81M | 0.25% |
| IBTG | -12.75% | $1.92B | 0.07% |
| XONE | -11.56% | $625.28M | 0.03% |
| BIL | -9.95% | $42.24B | 0.1356% |
| FXY | -9.22% | $816.38M | 0.4% |
| ULST | -8.22% | $654.75M | 0.2% |
| PSQA | -7.50% | $35.44M | 0.2% |
| SCHO | -6.96% | $11.03B | 0.03% |
| SPTS | -6.35% | $5.80B | 0.03% |
| UTWO | -6.31% | $379.52M | 0.15% |
| WEAT | -6.27% | $117.15M | 0.28% |
| XHLF | -5.83% | $1.73B | 0.03% |
| CTA | -5.59% | $1.06B | 0.76% |
| VGSH | -5.33% | $22.80B | 0.03% |
| TFLO | -5.16% | $6.82B | 0.15% |
| IBTH | -4.56% | $1.62B | 0.07% |
Current Value
$27.861 Year Return
Current Value
$27.861 Year Return
